HR. 1262Introduced
Mikaela Naylon Give Kids a Chance Act
Expand FDA authority over rare pediatric disease research by strengthening pediatric study enforcement, renewing pediatric incentives and funding, and clarifying orphan drug exclusivity rules
Plain-English overview
What this bill does
Expand FDA authority over rare pediatric disease research by strengthening pediatric study enforcement, renewing pediatric incentives and funding, and clarifying orphan drug exclusivity rules
Key points
- Authorize NIH pediatric research funding
- Modify pediatric cancer investigation requirements
- Allow FDA enforcement of study requirements
- Extend rare pediatric priority review vouchers
Current status
Where it stands
Status
Introduced
Latest action
2025-12-02 — Received in the Senate.
Related context
Topics and policy areas
undefinedArab-Israeli relationsBahrainCancerChild healthComputers and information technologyCongressional oversightDrug safety, medical device, and laboratory regulation